Source link : https://www.newshealth.biz/health-news/big-comeback-for-myeloma-drug-diy-cancer-therapy-gut-clues-to-bladder-cancer/
GSK announced that belantamab mafodotin (Blenrep) plus bortezomib (Velcade) and dexamethasone improved overall survival in relapsed/refractory multiple myeloma as compared with daratumumab (Darzalex) plus bortezomib and dexamethasone, coming full circle in a bid to return to the U.S. market after withdrawal in 2022. China-based BeiGene announced a rebranding as BeOne Medicines. (EndPoint News) MRI guidance […]
Author : News Health
Publish date : 2024-11-15 15:38:16
Copyright for syndicated content belongs to the linked Source.
